BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 224 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $17,995,000 | +219.7% | 123,502 | +204.8% | 0.28% | +201.1% |
| Q3 2021 | $5,628,000 | -52.6% | 40,515 | -66.9% | 0.09% | -58.6% |
| Q2 2021 | $11,883,000 | -7.6% | 122,408 | -35.0% | 0.22% | -22.1% |
| Q1 2021 | $12,867,000 | +187.5% | 188,256 | +207.5% | 0.28% | +61.0% |
| Q2 2020 | $4,476,000 | – | 61,221 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |